Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 2 institutions in 1 country.
Héloïse DébareInfectiologie et Santé Publique, National Research Institute for Agriculture, Food and the Environment, Université de Tours, 37000 Tours, France.ORCID 0000-0002-8300-6226
Nathalie MoiréInfectiologie et Santé Publique, National Research Institute for Agriculture, Food and the Environment, Université de Tours, 37000 Tours, France.
Firmin BaronInfectiologie et Santé Publique, National Research Institute for Agriculture, Food and the Environment, Université de Tours, 37000 Tours, France.ORCID 0000-0001-6199-0894
Louis LantierInfectiologie et Santé Publique, National Research Institute for Agriculture, Food and the Environment, Université de Tours, 37000 Tours, France.ORCID 0000-0003-3642-7500
Bruno HérautInfectiologie et Santé Publique, National Research Institute for Agriculture, Food and the Environment, Université de Tours, 37000 Tours, France.
Nathalie Van LangendonckService de Parasitologie-Mycologie-Médecine Tropicale, Centre Hospitalier Régional Universitaire de Tours, 37000 Tours, France.
Caroline Denevault-SabourinGroupe Innovation et Ciblage Cellulaire EA7501, Université de Tours, 37200 Tours, France.
Isabelle Dimier-PoissonInfectiologie et Santé Publique, National Research Institute for Agriculture, Food and the Environment, Université de Tours, 37000 Tours, France.
Françoise Debierre-GrockiegoInfectiologie et Santé Publique, National Research Institute for Agriculture, Food and the Environment, Université de Tours, 37000 Tours, France.ORCID 0000-0001-7050-3891
Université de Tours · FRCentre Hospitalier Universitaire de Tours · FR
Funding
British Society for Antimicrobial Chemotherapy GA2016_020PConseil Régional du Centre-Val de Loire PhD fellowshipuniversité de Tours Annual endowment
6 · The paper itself
Abstract
Treatments currently used to prevent congenital toxoplasmosis are non-specific of
Indexed as
AnimalsAnimals, NewbornCalcium-Calmodulin-Dependent Protein KinasesFemaleFetusImidazolesMaleMicePregnancyProtein Kinase InhibitorsProtein KinasesPyridazinesToxoplasmaToxoplasmosisCalcium-Calmodulin-Dependent Protein KinasesImidazolesProtein Kinase InhibitorsProtein KinasesPyridazinesSP230congenital toxoplasmosisimidazoazinesToxoplasma gondiitreatment
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Novel Calcium-Dependent Protein Kinase 1 Inhibitor Potently Prevents · full record | OpenQuestion